Phorum.com.gr

Despite geographical and seasonal variations,3, 4 the generally agreed incidence of Bell's palsy is 15–30 cases each year per 100 000 population. Ozonoff and colleagues2 rightly state that the predicted 12-month (annual) incidence of Bell's palsy inferred from mRNA vaccine trials is higher than that reported during the 2-month observation period of these studies. They concluded that the observed incidence of Bell's palsy in the mRNA vaccine arms was 3·5 to seven times higher than expected in the general population. However, safety data were collected for participants with a median follow-up of 2 months after the second dose; therefore, the data refer to an overall observation period of approximately 12 weeks from dose one. Given this, and considering Bell's palsy as the possible outcome of individual doses, the observed incidence in the mRNA vaccine trials would be roughly 1·5 to three times higher than in the general population (table).

Τζιτζιμιτζιχότζιρας έγραψε: 22 Αύγ 2021, 07:25 Ρε μεγάλε, δεν ξέρεις να το μεταφράσεις και θες να το συζητησουμε;

Bell's palsy is usually transient, with 70% of patients recovering within 6 months without treatment

Yochanan έγραψε: 22 Αύγ 2021, 10:06ψοφα

Καdy έγραψε: 22 Αύγ 2021, 11:07 χαιρομαι που παραδεχεστε την πιθανοτητα παραλυσης απο τα ασφαλη και αποτελεσματικα εμπολια
btw ο προβιντ εκτος απο ενα ελαφρυ βηχαλακι και πυρετο δεν προκαλει παραλυση προσωπου